Biomea Fusion Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell

5

BMEA
Biomea Fusion

Last Price:

8.86

Seasonality Move:

6.09%

Sell

45

NBY
NovaBay Pharmaceuticals

Last Price:

0.73

Seasonality Move:

-8.12%

Sell

5

Biomea Fusion (BMEA) is a Sell

Is Biomea Fusion a Buy, Sell or Hold?

The current Biomea Fusion [BMEA] share price is $8.91. The Score for BMEA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
BMEA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

45

NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

The current NovaBay Pharmaceuticals [NBY] share price is $0.76. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMEA Stock Price Chart

What is Biomea Fusion's stock price today?

The Biomea Fusion share price today is $8.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMEA is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

The NovaBay Pharmaceuticals share price today is $0.76
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

BMEA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0	Sell
Relative Strength Index (14 RSI):	37.8	Sell
Chaikin Money Flow:	202930	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(9.72 - 11.7)	Sell
Bollinger Bands (100):	(5.06 - 9.74)	Buy

NBY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.02	Buy
Relative Strength Index (14 RSI):	62.96	Buy
Chaikin Money Flow:	-5249	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.59 - 0.73)	Buy
Bollinger Bands (100):	(0.3 - 1.8)	Sell

BMEA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.39	Sell
20-day SMA:	10.85	Sell
50-day SMA:	9.39	Sell
200-day SMA:	10.66	Sell
8-day EMA:	9.89	Sell
20-day EMA:	10.31	Sell
50-day EMA:	9.53	Sell
200-day EMA:	10.26	Sell

NBY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.69	Buy
20-day SMA:	0.64	Buy
50-day SMA:	0.6	Buy
200-day SMA:	2.64	Sell
8-day EMA:	0.71	Buy
20-day EMA:	0.67	Buy
50-day EMA:	0.75	Buy
200-day EMA:	6.24	Sell

Biomea Fusion Earnings Growth & BMEA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $0.80 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Biomea Fusion Technical Analysis

	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5
	Oct								Nov
	23	24	25	28	29	30	31	01	04	05
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5
	Oct								Nov
	23	24	25	28	29	30	31	01	04	05
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):